Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Young & Rubicam (Y&R), often referred to as Young & Rubicam Brands, was a global marketing and communications powerhouse that operated as a subsidiary of WPP plc. Within the life sciences and healthcare sectors, the company was primarily known for its specialized healthcare communications arm, Sudler & Hennessey, which provided strategic branding and advertising services to major pharmaceutical and biotechnology firms. Y&R was founded in 1923 and grew into one of the world's largest advertising networks before merging with VML in 2018 to form VMLY&R. In 2023, the entity was further integrated into the VML network. As a service-oriented agency, the company does not develop proprietary therapeutic products or maintain a clinical drug pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Young and Rubicon Brands.